Chlorthalidone for Hypoparathyroidism

Joseph M. Gertner, Myron Genel, Uriel S. Barzel, Wadi N. Suki

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Abstract

To the Editor: Although we agree with Porter et al., in their study in the March 16 issue of the Journal, that hypercalciuria may be troublesome during the treatment of hypoparathyroidism with vitamin D and its metabolites, our recent experience suggests that adjunctive thiazide therapy does not invariably reduce urinary calcium or vitamin D requirements. A 14-year-old boy with hypoparathyroidism as part of the familial candida endocrinopathy syndrome has shown resistance to conventional doses of vitamin D and to 1:25-dihydroxyvitamin D. On 3 μg of the latter vitamin four times daily and 12 g of calcium chloride daily, his.

Original languageEnglish (US)
Pages (from-to)1478-1479
Number of pages2
JournalNew England Journal of Medicine
Volume298
Issue number26
DOIs
StatePublished - Jun 29 1978

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Chlorthalidone for Hypoparathyroidism'. Together they form a unique fingerprint.

Cite this